Neuvasq Biotechnologies is excited to attend the Bio-Neuroscience Summit 2025, the partnering and investment summit for global leaders in CNS neuroscience. This key event will be held in Amsterdam from February 25 to 27.
Our CEO, Emmanuel Lacroix, and our Business Alliance Manager, Isabel Vogel, will be there to connect and to exchange about our programs with potential new partners and investors.
🔬 Our company mission? Advancing innovative Wnt surrogate antibodies to restore neurovascular barriers in both ophthalmology and neurology.
👥 Attending? Let’s connect!
Follow our LinkedIn page for future updates.
 Cookie policy